New Drug Approvals Archive - January 2007
Olux-E (clobetasol propionate) Foam
Date of Approval: January 12, 2007
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
Lialda (mesalamine) Delayed Release Tablets
Date of Approval: January 16, 2007
Lialda (mesalamine) is a locally acting 5-aminosalicylic acid (5-ASA) indicated for the induction of remission in adults with active, mild to moderate ulcerative colitis and for the maintenance of remission of ulcerative colitis.
New Dosage Form Approved: January 26, 2007
Flector (diclofenac epolamine) Topical Patch
Date of Approval: January 31, 2007
Flector is a transdermal patch formulation of the nonsteroidal anti-inflammatory drug diclofenac, indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
NovoLog (insulin aspart)
Labeling Revision Approved: January 26, 2007
Labeling Revision Approved: July 14, 2011